Theravance Bio Ord (TBPH)
9.00 x 3 9.75 x 9
Pre-market by (Cboe BZX)
9.30 -0.01 (-0.11%) 03/26/25 [NASDAQ]
9.00 x 3 9.75 x 9
Pre-market 9.30 unch (unch) 16:00 ET
for Wed, Mar 26th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,418 | -55,193 | 872,132 | -199,426 | -278,017 |
| Depreciation Amortization | -799 | 104 | 3,035 | 4,812 | 3,628 |
| Income taxes - deferred | -7,573 | 3,207 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 750 | 6 | -1,612 | -3,534 | 3,658 |
| Other Working Capital | 20,355 | -8,340 | 42,350 | -39,549 | -37,777 |
| Other Operating Activity | 32,150 | 33,219 | -1,102,896 | 29,839 | 58,105 |
| Operating Cash Flow | $-11,535 | $-26,997 | $-186,991 | $-207,858 | $-250,403 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,838 | 71,377 | 17 | N/A | 19,942 |
| PPE Investments | -332 | -975 | 1,294 | -3,400 | -6,552 |
| Net Acquisitions | N/A | N/A | 2,709 | N/A | N/A |
| Purchase Of Investment | -140,743 | -134,534 | -103,145 | -158,305 | -401,987 |
| Sale Of Investment | 139,813 | 31,435 | 158,000 | 286,199 | 399,318 |
| Other Investing Activity | -2,292 | 0 | 1,095,134 | 0 | 0 |
| Investing Cash Flow | $12,284 | $-32,697 | $1,154,009 | $124,494 | $10,721 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 380,000 |
| Debt Repayment | N/A | N/A | -631,603 | -10,730 | -235,347 |
| Common Stock Issued | 607 | 618 | 802 | 111,651 | 144,977 |
| Common Stock Repurchased | -3,104 | -199,551 | -132,280 | -9,061 | -9,749 |
| Other Financing Activity | 0 | 0 | 4,275 | 0 | -16,796 |
| Financing Cash Flow | $-2,497 | $-198,933 | $-758,806 | $91,860 | $263,085 |
| Beginning Cash Position | 40,381 | 299,008 | 90,796 | 82,300 | 58,897 |
| End Cash Position | 38,633 | 40,381 | 299,008 | 90,796 | 82,300 |
| Net Cash Flow | $-1,748 | $-258,627 | $208,212 | $8,496 | $23,403 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,535 | -26,997 | -186,991 | -207,858 | -250,403 |
| Capital Expenditure | -332 | -2,488 | -572 | -3,406 | -6,616 |
| Free Cash Flow | -11,867 | -29,485 | -187,563 | -211,264 | -257,019 |